First human test of experimental cancer drug begins
NCT ID NCT06469008
Summary
This is an early-stage study testing a new drug called BL-B16D1 in people with advanced head and neck cancer or other solid tumors that have returned or spread. The main goals are to find a safe dose, see how the body processes the drug, and check for any early signs that it might help shrink tumors. The study is open to adults whose cancer has worsened despite standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai East Hospital
RECRUITINGShanghai, Shanghai Municipality, China
Contact
Conditions
Explore the condition pages connected to this study.